Guidelines for the management of adult myelodysplastic syndromes

被引:17
|
作者
Killick, Sally B. [1 ]
Ingram, Wendy [2 ]
Culligan, Dominic [3 ]
Enright, Helen [4 ]
Kell, Jonathan [2 ]
Payne, Elspeth M. [5 ]
Krishnamurthy, Pramila [6 ]
Kulasekararaj, Austin [6 ]
Raghavan, Manoj [7 ]
Stanworth, Simon J. [8 ,9 ]
Green, Simone [10 ]
Mufti, Ghulam [6 ]
Quek, Lynn [6 ]
Cargo, Catherine [11 ]
Jones, Gail L. [12 ]
Mills, Juliet [13 ,14 ]
Sternberg, Alex [15 ]
Wiseman, Daniel H. [16 ]
Bowen, David [11 ]
机构
[1] Univ Hosp Dorset NHS Fdn Trust, Royal Bournemouth Hosp, Bournemouth, Dorset, England
[2] Univ Hosp Wales, Cardiff, Wales
[3] Aberdeen Royal Infirm, Aberdeen, Scotland
[4] Trinity Coll Dublin, Tallaght Univ Hosp, Med Sch, Dublin, Ireland
[5] UCL, Canc Inst, London, England
[6] Kings Coll Hosp NHS Fdn Trust, London, England
[7] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[8] Univ Oxford, Oxford Univ Hosp NHS Trust, Oxford, England
[9] NHS Blood & Transplant, Oxford, England
[10] Hull & East Yorkshire Hosp NHS Trust, Kingston Upon Hull, N Humberside, England
[11] Leeds Teaching Hosp, St Jamess Inst Oncol, Leeds, W Yorkshire, England
[12] Newcastle Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
[13] Worcestershire Acute Hosp NHS Trust, Worcester, England
[14] Birmingham NHS Fdn Trust, Worcester, England
[15] Great Western Hosp NHS Fdn Trust, Swindon, Wilts, England
[16] Christie NHS Fdn Trust, Manchester, Lancs, England
关键词
myelodysplastic syndromes; MDS; guideline; management; STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; TRANSFUSION-DEPENDENT PATIENTS; CONVENTIONAL CARE REGIMENS; PROGNOSTIC SCORING SYSTEM; COLONY-STIMULATING FACTOR; IRON CHELATION-THERAPY; RANDOMIZED PHASE-III; LABILE PLASMA IRON; RISK MDS PATIENTS;
D O I
10.1111/bjh.17612
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:267 / 281
页数:15
相关论文
共 50 条
  • [21] Novel agents for the management of myelodysplastic syndromes
    Meletis, John
    Viniou, Nora
    Terpos, Evangelos
    MEDICAL SCIENCE MONITOR, 2006, 12 (09): : RA194 - RA206
  • [22] Management of Myelodysplastic Syndromes: 2008 Update
    Scott, Bart L.
    Estey, Eli
    ONCOLOGY-NEW YORK, 2008, 22 (12): : 1344 - 1352
  • [23] Azacitidine in the management of patients with myelodysplastic syndromes
    Khan, Cyrus
    Pathe, Neeta
    Fazal, Salman
    Lister, John
    Rossetti, James M.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (06) : 355 - 373
  • [24] Individualized management and therapy of myelodysplastic syndromes
    Stauder, Reinhard
    Wimazal, Friedrich
    Noesslinger, Thomas
    Krieger, Otto
    Sperr, Wolfgang R.
    Sill, Heinz
    Pfeilstoecker, Michael
    Valent, Peter
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 (17-18) : 523 - 537
  • [25] Management of myelodysplastic syndromes in 2019: An update
    Comont, T.
    Delavigne, K.
    Cougoul, P.
    Bertoli, S.
    Delabesse, E.
    Fenaux, P.
    Beyne-Rauzy, O.
    REVUE DE MEDECINE INTERNE, 2019, 40 (09): : 581 - 589
  • [26] Myelodysplastic Syndromes, Version 2.2017 Clinical Practice Guidelines in Oncology
    Greenberg, Peter L.
    Stone, Richard M.
    Al-Kali, Aref
    Barta, Stefan K.
    Bejar, Rafael
    Bennett, John M.
    Carraway, Hetty
    De Castro, Carlos M.
    Deeg, H. Joachim
    DeZern, Amy E.
    Fathi, Amir T.
    Frankfurt, Olga
    Gaensler, Karin
    Garcia-Manero, Guillermo
    Griffiths, Elizabeth A.
    Head, David
    Horsfall, Ruth
    Johnson, Robert A.
    Juckett, Mark
    Klimek, Virginia M.
    Komrokji, Rami
    Kujawski, Lisa A.
    Maness, Lori J.
    O'Donnell, Margaret R.
    Pollyea, Daniel A.
    Shami, Paul J.
    Stein, Brady L.
    Walker, Alison R.
    Westervelt, Peter
    Zeidan, Amer
    Shead, Dorothy A.
    Smith, Courtney
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2017, 15 (01): : 60 - 87
  • [27] AGGRESSIVE CHEMOTHERAPY IN ADULT PRIMARY MYELODYSPLASTIC SYNDROMES (MDS)
    FENAUX, P
    LAI, JL
    ESTIENNE, MH
    DEMINATTI, M
    BAUTERS, F
    BLUT, 1988, 56 (06): : C20 - C20
  • [28] Differentially expressed genes in adult familial myelodysplastic syndromes
    A Pradhan
    A Mijovic
    K Mills
    P Cumber
    N Westwood
    G J Mufti
    F V Rassool
    Leukemia, 2004, 18 : 449 - 459
  • [29] Myelodysplastic Syndromes, Version 2.2025 Featured Updates to the NCCN Guidelines
    Greenberg, Peter L.
    Stone, Richard M.
    Abaza, Yasmin
    Al-Kali, Aref
    Anand, Sarah
    Ball, Brian
    Bennett, John M.
    Borate, Uma
    Brunner, Andrew M.
    Chai-Ho, Wanxing
    Curtin, Peter
    Dezern, Amy E.
    Gaensler, Karin
    Gahvari, Zhubin
    Garcia-Manero, Guillermo
    Griffiths, Elizabeth A.
    Haque, Tamanna
    Jacoby, Meagan
    Jonas, Brian A.
    Keel, Sioban
    Khanal, Rashmi
    Kishtagari, Ashwin
    Madanat, Yazan
    Maness, Lori J.
    Mccurdy, Shannon R.
    Mcmahon, Christine
    Odenike, Olatoyosi
    Osman, Afaf
    Reddy, Vishnu V.
    Sallman, David A.
    Sayar, Hamid
    Shallis, Rory
    Singh, Abhay
    Tanaka, Tiffany
    Thota, Swapna
    Kovach, Emily
    Nguyen, Jamie
    Hochstetler, Cindy
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2025, 23 (03): : 66 - 75
  • [30] Genetic Predisposition to Myelodysplastic Syndromes: A Challenge for Adult Hematologists
    Crisa, Elena
    Boggione, Paola
    Nicolosi, Maura
    Mahmoud, Abdurraouf Mokhtar
    Al Essa, Wael
    Awikeh, Bassel
    Aspesi, Anna
    Andorno, Annalisa
    Boldorini, Renzo
    Dianzani, Irma
    Gaidano, Gianluca
    Patriarca, Andrea
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (05) : 1 - 19